
CRO Expertise
The following toxicology services are offered by our parent company JOINN Laboratories.
- Pharmacology & pharmacodynamics
- Pharmacokinetics
- General toxicology
- Non-clinical safety assessment
- Genotoxicity
- Safety pharmacology
- DART – Seg I, II, III
- Carcinogenicity
- Stem cells/CAR-T
- Ophthalmology
- Inhalation toxicity
- Global IND filling support
Credentials
- AAALAC Accredited
- US FDA GLP Inspected
- NMPA GLP Certified
- OECD GLP Certified
- PMDA GLP Inspected
- MFDS GLP Inspected
- CNAS/ILAC-MRA Certified
Contact International Liaison Team for Inquiries
In response to NHP availability and the escalating expense which accompanies the scarcity of models, requests for quotes to procure study space in China with our parent company JOINN Laboratories are rising.
In an increasingly virtual world, your study will be managed seamlessly whether it is placed in the U.S. or China. Our International Liaison Team manages all requests for studies placed in China.
JOINN is one of the largest CROs in China and is averaging 30% savings in relation to studies conducted in the U.S. as well as improved study start times and abundant model availability.

Senior Director
of Toxicology
JOINN Laboratories
Full Bio

Chief Business Officer
Biomere
Full Bio
Toxicology Team

Facility Manager
JOINN Laboratories
Full Bio

Assistant Chief
Operating Officer
Senior Director
of Toxicology
JOINN Laboratories
(Beijing)
Full Bio

Senior Director
of Toxicology
JOINN Laboratories
Full Bio

Vice President
and FM
JOINN Laboratories
(Suzhou)
Full Bio

Senior Scientist
of Non-clinical Science
JOINN Laboratories
(Suzhou)
Full Bio

Director of Toxicology
(Dept. #1)
JOINN Laboratories
(Suzhou)
Full Bio

Director of Toxicology
JOINN Laboratories
(Beijing)
Full Bio

Director of
Ophthalmology
JOINN Laboratories
Full Bio

Director of Toxicology
JOINN Laboratories
(Beijing)
Full Bio

Director of Toxicology
Division No. 2
JOINN Laboratories
(Suzhou)
Full Bio

Director of Macromolecular
Analysis
JOINN Laboratories
(Suzhou)
Full Bio
White Papers

BLOG POST: An Overview of Cell-Based Models To Evaluate Kidney Toxicity
BLOG POST: Models and Markers To Evaluate Drug Induced Liver Injury (DILI)/figcaption>
Publications
JOINN Locations
